Federal authorities have leveled serious charges against the operators of a Central California biolab. Jia Bei Zhu and Zhaoyan Wang are accused of conspiracy and wire fraud for selling fraudulent COVID-19 test kits, falsely labeled as U.S.-made, between 2020 and 2023.
The duo’s alleged deception generated over $1.7 million in profits, leading to a 12-count superseding indictment.
Fraudulent Practices and Charges
The U.S. Attorney’s Office has accused Zhu and Wang of orchestrating a complex fraud scheme that exploited the high demand for COVID-19 test kits.
Between August 2020 and March 2023, the two allegedly imported thousands of test kits from a China-based company they controlled, falsely marketing them as products made in the United States.
They also claimed that the test kits were approved by the FDA and produced in partnership with CDC-certified labs.
Accusations Against Zhu and Wang |
Details |
|---|---|
| Mislabeling Test Kits | Claimed U.S. origin |
| False Approval Claims | Falsely stated FDA approval |
| Import Fraud | Declared COVID-19 tests as pregnancy kits |
| Conspiracy and Wire Fraud Charges | Accumulated over $1.7 million in fraudulent sales |
These fraudulent practices are the basis of the conspiracy and wire fraud charges Zhu and Wang now face. They allegedly denied buyers access to inspect their Fresno and Reedley facilities, citing false reasons like ongoing construction and confidential technology.
This deception helped conceal the true origins of the test kits and the illegal nature of their business.
Legal Repercussions and Investigation
Zhu and Wang’s actions have brought them under intense scrutiny from federal agencies, including the FBI and the FDA’s Office of Criminal Investigations. If convicted, they each face up to 20 years in prison for the conspiracy and wire fraud charges.
Additionally, they could receive an extra three years for distributing adulterated and misbranded medical devices. Zhu may also face another five years for making false statements to authorities.
- 20 Years: Maximum sentence for conspiracy and wire fraud
- 3 Years: Additional sentence for distribution of adulterated devices
The federal indictment serves as a reminder of the serious legal consequences of fraud, especially when it involves public health and safety. The FBI and FDA’s involvement underscores the gravity of these allegations and the commitment to holding those responsible accountable.
Ongoing Legal Proceedings
Currently, Jia Bei Zhu remains in custody pending his federal trial, with the next status conference scheduled for September 11, 2024. Zhaoyan Wang, however, is not in custody.
The outcome of this case will likely set a precedent for similar cases of fraud related to public health crises.
The case highlights the broader issue of fraudulent medical products that proliferated during the COVID-19 pandemic, endangering public health and eroding trust in medical institutions.
As this legal battle unfolds, it will be closely watched by both legal experts and the public.
Sources: THX News & Federal Bureau of Investigations.
